Saturday, October 3, 2026

USD/CNH Bearish By 2% In The Last 10 Sessions

ViaNews Editorial Team

January 26, 2024

USD/CNH Bearish By 2% In The Last 10 Sessions

(VIANEWS) - USD/CNH (USDCNH) has been up by 2.02% for the last 10 sessions. At 07:10 EST on Friday, 26 January, USD/CNH (USDCNH) is $7.18.

USD/CNH's yearly highs and lows, it's 0.061% up from its 52-week low and 0.16% down from its 52-week high.

News about

  • Eur/usd forex signal: bullish “v” at $1.0822 - 24 January 2024. According to DailyForex on Wednesday, 24 January, "My previous EUR/USD signal on 22ndJanuarywas not triggered as there was insufficiently bullish price action when the support level at $1.0888 was first reached that day.", "In my previous analysis ofthe EUR/USD currency pairtwo days ago, I wrote that the price would probably not move much today, giving little trading opportunities except perhaps for scalpers."
  • Eur/usd climbs sharply despite strong US pmis, ahead of ecb’s decision. According to FXStreet on Wednesday, 24 January, "The EUR/USD dipped and formed a 'bearish engulfing' chart pattern, which is being invalidated by a leg-up that has breached the 50-day moving average at 1.0922 and tests the 61.8% Fibonacci retracement at 1.0931. "
  • Eur/usd analysis: euro under pressure, eyes on ISM data - 24 January 2024. According to DailyForex on Wednesday, 24 January, "Based on the performance on the daily chart, the overall trend for the EUR/USD pair is bearish. ", "Moreover, technical indicators may shift towards strong oversold levels if the EUR/USD price moves towards support levels at 1.0800, 1.0745, and 1.0690 successively. "
  • According to FXStreet on Wednesday, 24 January, "The re-emergence of the appetite for the risk complex weighed on the Dollar and lifted EUR/USD past 1.0900. ", "In Europe, EUR/USD surpassed the 1.0900 hurdle and reached fresh multi-day highs, although the move fizzled out towards the end of the NA session. "

More news about USD/CNH (USDCNH).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com